Formulation Philosophy

We don’t formulate products.
We engineer clinical outcomes.

63+ clinical-grade protocols. Every active concentration published. Every mechanism of action documented. Full ingredient transparency as standard.

63+
Protocols
7
Clinical Categories
470+
Clinics
3
Countries
Our Standard

What We Publish. What Others Don't.

Published Concentrations

Every active agent concentration documented on every protocol.

Named Active Architectures

Branded formulation systems with defined mechanisms of action.

pH-Specified Formulations

Exact pH ranges published for predictable penetration depth.

Prodermic 580 Yellow Peel — full ingredient label with published concentrations
prodermic 580 · Every concentration published on label
Our Approach

Named Formulation Systems

Every Prodermic protocol is built around a named formulation system — a branded methodology that defines the mechanism, the active architecture, and the clinical endpoint.

prodermic 580 · Yellow Peel

Quad-Pathway Depigmentation™

Four active agents attacking melanin synthesis at different biochemical points. Tyrosinase inhibition. Melanin transfer disruption. Epidermal turnover acceleration. Antioxidant conversion.

Kojic AcidArbutinAzelaic AcidAscorbic Acid
View Protocol
prodermic 420 · Black Peel

Carbon Detox Architecture™

Activated carbon matrix combined with a controlled acid delivery system. Deep-pore adsorption. Sebum normalization. Toxin clearance without compromising barrier integrity.

Activated CarbonGlycolic AcidLactic Acid
View Protocol
prodermic 590 · Glutathione Peel

Master Antioxidant Protocol™

Glutathione-led eumelanin-to-pheomelanin conversion supported by multi-acid synergy. The body's master antioxidant, deployed at clinical concentrations.

GlutathioneGlycolic AcidLactic AcidCitric Acid
View Protocol
prodermic 460 · Acne Protocol

Dual-Keratolytic System™

Two lipophilic keratolytic agents working in concert. Comedolytic action meets antibacterial efficacy. Resorcinol + Salicylic Acid in calibrated proportions for inflammatory and non-inflammatory acne.

ResorcinolSalicylic Acid
View Protocol
prodermic 612 · TCA Protocol

Controlled-Depth Resurfacing™

Precision TCA delivery with acid modulation buffer. Controlled frosting endpoints. Predictable depth penetration for dermal remodeling in experienced hands.

Trichloroacetic AcidAcid Modulation Buffer
View Protocol
prodermic 585 · Gentle Retinol

Retinoid Multi-Pathway Architecture™

Seven-agent retinoid system combining retinol with phytic, lactic, and salicylic acids. Controlled epidermal turnover without aggressive peeling. Anti-aging with minimal downtime.

RetinolPhytic AcidLactic AcidSalicylic Acid
View Protocol
prodermic 565 · Melasmonil

Gentle Quad-Acid Correction™

Four-acid depigmentation system calibrated for sensitive Fitzpatrick IV–VI skin. Glycolic-lactic-citric-kojic synergy at conservative concentrations for melasma without barrier compromise.

Glycolic AcidLactic AcidCitric AcidKojic Acid
View Protocol
prodermic 552 · Party Peel

Rapid Radiance Architecture™

Three-agent instant glow system. Glycolic-lactic exfoliation paired with arginine vasodilation for immediate luminosity. Zero downtime. Pre-event protocol.

Glycolic AcidLactic AcidArginine
View Protocol
prodermic 610 · Vitamin C Peel

Glycolic-Antioxidant Fusion™

Glycolic acid resurfacing combined with L-Ascorbic Acid antioxidant defense and niacinamide barrier support. Dual-action brightening through exfoliation and oxidative protection.

Glycolic AcidVitamin CNiacinamide
View Protocol
prodermic 595 · Scar Protocol

Keto-Acid Scar Architecture™

Pyruvic-lactic dual keto-acid system for controlled dermal remodeling. Medium-depth penetration targeting atrophic scarring and photodamage with predictable frosting endpoints.

Pyruvic AcidLactic Acid
View Protocol
Formulation Science

How Multi-Pathway Formulations Work

Using the 580 Yellow Peel as an example — four biochemical pathways working in concert to address hyperpigmentation from multiple angles simultaneously.

01

Tyrosinase Inhibition

Kojic Acid + Arbutin

Blocks the enzyme responsible for melanin production at the source.

02

Melanin Transfer Disruption

Niacinamide

Prevents synthesized melanin from reaching the skin surface.

03

Epidermal Turnover

Glycolic Acid + Lactic Acid

Accelerates removal of existing pigmented cells from the epidermis.

04

Antioxidant Conversion

Ascorbic Acid + Glutathione

Converts dark eumelanin to lighter pheomelanin.

Four pathways. One protocol. Predictable outcomes.
Documented Outcomes

Clinical Validation

Standardized photography. Controlled protocols. Measurable outcomes across Fitzpatrick III–V skin types.

470+Clinics using Prodermic
III–VFitzpatrick range
3–6Sessions avg. protocol
6–12Weeks to visible outcome

All patients provided informed consent for photography. Images unedited except standard color calibration. Individual outcomes depend on compliance, skin type, and condition severity.

Quality Assurance

Manufacturing Standards

Every protocol is manufactured under pharmaceutical-grade conditions with full regulatory compliance and batch traceability.

GMP

GMP Certified

Good Manufacturing Practice certified production facility with controlled environments.

ISO

ISO 9001:2015

Quality management system certified across formulation, production, and distribution.

DCGI

DCGI Registered

Drug Controller General of India registered. Full regulatory compliance.

24m

Stability Tested

24-month accelerated stability testing on every formulation before release.

pH

pH Documented

Exact pH ranges published for every protocol. Predictable penetration depth.

COA

Certificate of Analysis

Batch-level COA available on request for every shipment.

Access the complete protocol library.

63+ clinical-grade formulations with full ingredient transparency. Every concentration published. Every protocol documented.